Found: 9
ОБЗОР2026 · pp. 107–116
Morozov A.M., Sorokovikova T.V., Kuzmenko A.D., Shablinskaya K.S.
Introduction. Cerebrovascular diseases are a heterogeneous group of conditions shaped by the interaction of polygenic susceptibility, rare monogenic variants, vascular remodeling, neuroinflammation, dysregulated hemostasis, and epigenetic reprogramming. Recent…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 3–8
Khaspekov L.G., Mudarisova R.S., Kolotyeva N.A., Salmina A.B., Li W., Illarioshkin S.N.
Introduction. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder, the primary pathological feature of which is the death of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of aggregated α-synuclein. Th…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 3–9
Tukhvatullin A.V., Kuzmina U.S., Bakhtiyarova K.Z., Vakhitova Yu.V.
Introduction. Glutamate receptors are involved in modulating key T-lymphocyte functions, including proliferation, chemotaxis, and others. In the context of the immunopathogenesis of multiple sclerosis (MS), studying the mechanisms underlying these effects is o…
ОБЗОР2025 · pp. 21–31
Evert L.S., Potupchik T.V., Veselova O.F., Svetlakova I.S., Panchenko B.A., Kudasheva R.R., Melnikova A.N.
Objective. To analyze the potential risks and technological limitations of using genome editing methods in neurodegenerative diseases, as well as to assess the prospects for their implementation in clinical practice. Material and methods. A systematic analysis…
ОБЗОР2024 · pp. 29–39
Tereshchenko C.Yu., Potupchik T.V., Evert L.S., Kovalchuk V.A., Filippova M.A., Magalova A.R.
The purpose of this review is to analyze current advances in the field of genome editing, their application for the modeling and treatment of neurodegenerative diseases, as well as to discuss current limitations and prospects for overcoming barriers in clinica…
ОБЗОР2024 · pp. 14–23
Venediktov A.A., Kuzmin E.A., Pokidova K.S., Oganesyan D.M., Stepanian A.T., Boronikhina T.V., Piavchenko G.A., Kuznetsov S.L
Introduction. Many chemical compounds affect brain neurons differently than other cell populations. This is provided by the protective potential of the blood-brain barrier (BBB). One of the compounds capable of passing through the BBB is bacterial lipopolysacc…
ОБЗОР2023 · pp. 34–39
Yasenyavskaya A.L., Tsibizova A.A., Samotrueva M.A.
Introduction. The review is devoted to the analysis of modern concepts of the neurodegenerative properties of depression. Depression is now regarded as the most common mental illness with significant social consequences. The aim of the study is to determine th…
ОБЗОР2021
Chrishtop V.V., Rumyantseva T.A., Nikonorova V.G.
A wide range of diseases: stroke, Alzheimer’s disease, brain injury, etc., is based on cerebral hypoperfusion. Vascular dementia, which is the equivalent of cerebral hypoperfusion, is one of the most common cognitive disorders in older people following Alzheim…
ОБЗОР2020
Nozdrachev A.D., Goryukhina O.A., Martyushin S.V., Mishchenko I.V.
The prospect of developing transport systems using histones for delivery of therapeutic agents possessing poor penetration characteristics through cellular membranes and tissue barriers has been investigated. A review of the literary, as well as proper data, a…